1. Home
  2. ETON vs VATE Comparison

ETON vs VATE Comparison

Compare ETON & VATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eton Pharmaceuticals Inc.

ETON

Eton Pharmaceuticals Inc.

HOLD

Current Price

$16.74

Market Cap

498.8M

Sector

Health Care

ML Signal

HOLD

Logo INNOVATE Corp.

VATE

INNOVATE Corp.

HOLD

Current Price

$4.73

Market Cap

70.3M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ETON
VATE
Founded
2017
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Metal Fabrications
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
498.8M
70.3M
IPO Year
2018
1996

Fundamental Metrics

Financial Performance
Metric
ETON
VATE
Price
$16.74
$4.73
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$29.67
N/A
AVG Volume (30 Days)
233.1K
32.3K
Earning Date
11-06-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$70,316,000.00
$1,099,900,000.00
Revenue This Year
$107.23
N/A
Revenue Next Year
$29.72
N/A
P/E Ratio
N/A
N/A
Revenue Growth
102.77
N/A
52 Week Low
$11.09
$4.05
52 Week High
$23.00
$13.79

Technical Indicators

Market Signals
Indicator
ETON
VATE
Relative Strength Index (RSI) 52.30 45.69
Support Level $16.27 $4.75
Resistance Level $17.33 $5.35
Average True Range (ATR) 0.64 0.35
MACD 0.15 0.03
Stochastic Oscillator 68.35 42.85

Price Performance

Historical Comparison
ETON
VATE

About ETON Eton Pharmaceuticals Inc.

Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.

About VATE INNOVATE Corp.

Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments which are; The infrastructure segment is comprised of DBM Global Inc, a fully integrated industrial construction, structural steel, and facility maintenance provider that provides fabrication and erection of structural steel and heavy steel plate services, The Life Sciences segment is comprised of Pansend Life Sciences which seeks to develop products to treat early osteoarthritis of the knee and aesthetic and medical technologies for the skin, and Spectrum segment is comprised of HC2 Broadcasting Holdings Inc which operates over-the-air broadcasting station across the United States.

Share on Social Networks: